Just in advance of Medicare’s Annual Enrollment Period (AEP), the research and advisory services firm, Avalere Health, released an analysis of Medicare Part D drug plan costs.
Average premiums are expected to rise by 6% next year. But that overall number only tells part of the story. Avalere took a deeper look at the market to uncover some steep increases in a number of the most popular plans around the country. Some of the top plans, in fact, are gearing up for double-digit cost increases.
Read more of my article, “Top Medicare Part D Plan Costs Spike in 2013” on WebMD.